Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Zeng

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
British Journal of Cancer|January 18, 2022
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerZhaopei Liu, Han Zeng, Kaifeng Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
ARID1A loss plus CD8+ T cell infiltration associate with favorable clinical outcomes in urothelial carcinomaZhaopei Liu, Lingkai Zhang, Kaifeng Jin, et al.
Journal of Microbiology and Biotechnology|March 30, 2023
A High-Throughput Method Based on Microculture Technology for Screening of High-Yield Strains of Tylosin-Producing <i>Streptomyces fradiae</i>Zhiming Yao, Jingyan Fan, Jun Dai, et al.
Cancer|December 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinomaLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2022
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerYanze Yu, Han Zeng, Kaifeng Jin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 1, 2025
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremiaMeng-Yu Kong, Sun-Ting Qin, Rui-Yun Ling, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2021
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder CancerMengmeng Sun, Han Zeng, Kaifeng Jin, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpressionKaifeng Jin, Yawei Ding, Jingtong Xu, et al.
Cancer|June 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinomaJiaxing Sun, Kaifeng Jin, Yawei Ding, et al.
Journal for Immunotherapy of Cancer|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinomaYawei Ding, Kaifeng Jin, Xiaohe Su, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
British Journal of Cancer|January 18, 2022
TIGIT and PD-1 expression atlas predicts response to adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancerZhaopei Liu, Han Zeng, Kaifeng Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2025
ARID1A loss plus CD8+ T cell infiltration associate with favorable clinical outcomes in urothelial carcinomaZhaopei Liu, Lingkai Zhang, Kaifeng Jin, et al.
Journal of Microbiology and Biotechnology|March 30, 2023
A High-Throughput Method Based on Microculture Technology for Screening of High-Yield Strains of Tylosin-Producing <i>Streptomyces fradiae</i>Zhiming Yao, Jingyan Fan, Jun Dai, et al.
Cancer|December 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinomaLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2022
Immune inactivation by neuropilin-1 predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancerYanze Yu, Han Zeng, Kaifeng Jin, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 1, 2025
Impact of therapeutic drug monitoring on microbiological eradication in patients with staphylococcus aureus bacteremiaMeng-Yu Kong, Sun-Ting Qin, Rui-Yun Ling, et al.
Cancer Immunology, Immunotherapy : CII|October 30, 2021
Infiltration and Polarization of Tumor-associated Macrophages Predict Prognosis and Therapeutic Benefit in Muscle-Invasive Bladder CancerMengmeng Sun, Han Zeng, Kaifeng Jin, et al.
Journal for Immunotherapy of Cancer|January 6, 2025
Lethal clinical outcome and chemotherapy and immunotherapy resistance in patients with urothelial carcinoma with MDM2 amplification or overexpressionKaifeng Jin, Yawei Ding, Jingtong Xu, et al.
Cancer|June 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinomaJiaxing Sun, Kaifeng Jin, Yawei Ding, et al.
Journal for Immunotherapy of Cancer|May 20, 2026
Aberrant p53 fuels macrophage immunoregulatory polarization and refractory clinical outcome in urothelial carcinomaYawei Ding, Kaifeng Jin, Xiaohe Su, et al.
Pageof 13